The NIRVANA field-test kit
Credit: Mo Li/KAUST
The field test, called NIRVANA, can simultaneously detect and sequence SARS-CoV-2, influenza and other viruses
Clinicians using a new viral screening test can not only diagnose COVID-19 in a matter of minutes with a portable, pocket-sized machine, but can also simultaneously test for other viruses—like influenza—that might be mistaken for the coronavirus. At the same time, they can sequence the virus, providing valuable information on the spread of COVID-19 mutations and variants. The new test, dubbed NIRVANA, was described online today by a multi-institution team of scientists in the journal Med.
“This is a virus detection and surveillance method that doesn’t require an expensive infrastructure like other approaches,” says Juan Carlos Izpisua Belmonte, co-corresponding author and a professor in Salk’s Gene Expression Laboratory. “We can accomplish with one portable test the same thing that others are using two or three different tests, with different machines, to do.”
Around the world, more than 100 million people have been infected with SARS-CoV-2, the virus that causes COVID-19. A staggering 500,000 Americans have died from COVID-19 to date. Testing the population is key to stopping the spread of the virus. In addition, tracking the spread of new SARS-CoV-2 variants—some of which could respond differently to treatments or vaccines—is critical.
Today, the standard approach to determining whether a nasal swab is positive for COVID-19 is to run a polymerase chain reaction (PCR) test to detect genetic material from the SARS-CoV-2 virus. If the sample is negative, however, patients and clinicians don’t get any information on what might be causing the coronavirus-like symptoms—unless they run separate PCR tests, using different swab samples, for other viruses. And if the sample is positive for SARS-CoV-2, they don’t learn which COVID-19 variant a patient is infected with unless another set of tests is run; those require a large and expensive next-generation gene-sequencing machine.
Last summer, Mo Li, an assistant professor of bioscience at King Abdullah University of Science and Technology in Saudi Arabia, was pondering ways he could lend his expertise in genetic engineering and nanopore sequencing to combatting the COVID-19 pandemic. Li, who previously spent six years as a Salk postdoctoral researcher in the Izpisua Belmonte lab, wondered whether a gene-detection approach called isothermal recombinase polymerase amplification (RPA) coupled with real-time nanopore sequencing might be more useful—and faster, cheaper and more portable—than the current COVID-19 testing approach. He teamed up with Izpisua Belmonte to find out.
Unlike PCR, which cycles through lower and higher temperatures to separate DNA strands and copy them, RPA uses proteins—rather than temperature changes—to accomplish the same thing in only 20 minutes. The technology lets researchers copy longer stretches of DNA, and probe for multiple genes at the same time.
“We quickly realized that we could use this technique to not only detect SARS-CoV-2, but other viruses at the same time,” says Li.
In the new paper, Li and Izpisua Belmonte describe a small, portable device that can screen 96 samples at the same time using the RPA assay. They call the method NIRVANA, for “nanopore sequencing of isothermal rapid viral amplification for near real-time analysis.”
The scientists designed NIRVANA to simultaneously test samples for COVID-19, influenza A, human adenovirus, and non-SARS-CoV-2 human coronavirus. In just 15 minutes, the researchers report, the device begins to report positive and negative results. And within three hours, the device finalizes results on all 96 samples—including the sequences of five regions of SARS-CoV-2 that are particularly prone to accumulate mutations leading to new variants such as the B.1.1.7 variant identified in the UK.
Li and Izpisua Belmonte tested NIRVANA on 10 samples known to be positive for SARS-CoV-2, 60 samples of unknown SARS-CoV-2 status, as well as samples of municipal wastewater harboring the SARS-COV-2 virus and others. In all cases, the assay was able to correctly identify which viruses were present. The sequencing data also allowed them to narrow down the origin of SARS-CoV-2 in positive samples; differentiating strains from China and Europe, for instance.
“The design of this assay is really flexible, so it’s not just limited to the examples we’ve shown,” says Li. “We can easily adapt it to tackle another pathogen, even something new and emergent.”
With the small size and portability of the NIRVANA workflow, it could be used for fast virus detection at schools, airports or ports, the researchers say. It also could be used to monitor wastewater or streams for the presence of new viruses.
“The pandemic has provided two important lessons: first, test widely and quickly, and second, know your variants. Our NIRVANA method provides a promising solution to these two challenges not only for the current pandemic but also for possible future ones,” says Izpisua Belmonte, who holds the Roger Guillemin Chair at Salk. Market analysis would be required to determine whether the initial cost of commercialization—and the constant tweaks to the test needed to make sure it detected new variants or new viruses of interest—are worth it, Belmonte adds.
Original Article: Fast, portable test can diagnose COVID-19 and track variants
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Virus field test
- Rapid Diagnostic Detects Ebola Earlier than Gold Standard Teston April 12, 2021 at 1:25 am
at $22.50 per test, the platform is expensive and, because it is lab-based, can be slow. In some studies, the median time required to confirm a diagnosis in the field is 6 days, making it a suboptimal ...
- Thailand hits new daily record with nearly 1,000 virus caseson April 11, 2021 at 10:45 pm
The expanding outbreak comes after the country kept the virus largely in check for most of last year ... He said people should be working from home and exercise vigilance. Tests among those infected ...
- The Latest: MLB has 4 positive virus tests in past weekon April 9, 2021 at 9:07 pm
Major League Baseball had two players and two staff members test positive for the coronavirus over the past ... they will open their season in New Jersey next month while their home field is renovated ...
- Sachin Tendulkar tests positive for coronaviruson March 26, 2021 at 11:33 pm
The cricketing legend said in a tweet that he has been tested positive for the virus today ... have stepped on the field. Sachin Tendulkar is the leading run scorer in Tests, with 15,921 runs ...
- COVID Accelerated Consumer-Friendly Testing Trends That Were Already Underwayon March 25, 2021 at 12:11 pm
“But most people in the infectious disease expert field feel COVID will probably be something ... it will be highly likely that combination testing for more than one type of virus will become ...
Go deeper with Google Headlines on:
Virus field test
Go deeper with Bing News on:
Viral screening test
- ‘Chucky doll in a dog’s body’: Woman’s post about ‘demonic’ foster dog goes viralon April 11, 2021 at 4:44 pm
(NEXSTAR) – A New Jersey woman’s post advertising what she described as a “demonic” chihuahua for adoption has gone viral for ... mandatory use of test kits for COVID-19 being rolled out across the ...
- Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)on April 9, 2021 at 1:45 am
Diagnosis of HCV infection can be done by screening for anti-HCV antibodies along with a serological test to confirm the viral infection.Nucleic acid test for HCV ribonucleic acid (RNA ...
- Reopening schools: USC researchers seek the most effective way to test students for COVIDon April 8, 2021 at 3:43 pm
With many schools set to reopen for part-time in-person learning, USC researchers set out to study the most effective way to test children for COVID-19.
- Rapid, Portable COVID-19 Test Could Help Track Variantson April 8, 2021 at 10:26 am
Based on their findings and considering the small size and portability of the test, the investigators said it could be used for fast virus detection in schools and airports.
- Rapid COVID tests used twice weekly could detect most contagious kidson April 8, 2021 at 6:19 am
Last year, the U.S. government purchased 150 million BinaxNOW rapid antigen COVID-19 tests and began distributing them. One of the goals was to safely reopen schools. However, little data was ...